FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a novel compound of 2-[6-methyl-4-(thietan-3-yloxy)pyrimidin-2-ylthio]acetohydrazide of maleic acid of formula I with antimicrobial activity.
(1).
EFFECT: invention expands the range of antimicrobial agents.
1 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 2-[6-METHYL-4-(TIETANE-3-YLOXY)PYRIMIDINE-2-YLTHIO] ACETIC ACID METHYLIDENHYDRAZIDE WITH ANTIOXIDANT ACTIVITY | 2016 |
|
RU2626651C1 |
| N'-PYRIDIN-4-YLMETHYLENE-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE, HAVING ANTIAGGREGATION AND ANTICOAGULANT ACTIVITY | 2024 |
|
RU2825129C1 |
| 2-BROMO-1-(4-BROMOPHENYL)ETHYLIDENE-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE, HAVING ANTICOAGULATION AND ANTIAGGREGATION ACTIVITY | 2024 |
|
RU2824993C1 |
| N-BUTYL-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETAMIDE EXHIBITING ANTIOXIDANT ACTIVITY | 2024 |
|
RU2824634C1 |
| UBIQUITIN-SPECIFIC PROTEASE 7 PROTEIN INHIBITOR MOLECULES | 2022 |
|
RU2814272C1 |
| USE OF N'-{1-[6-METHYL-3-(TIETANE-3-YL)-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL]PROPAN-2-YLIDENE} ISONICOTINOHYDRAZIDE AS MEANS THAT STIMULATE TISSUE REGENERATION | 2023 |
|
RU2813148C1 |
| DERIVATIVES OF THIAETANE-CONTAINING 1-BUTYL-3-METHYLXANTHINES EXHIBITING ANTIOXIDANT ACTIVITY | 2020 |
|
RU2740926C1 |
| ETHYLIDENE HYDRAZIDE OF 2-[6-METHYL-1-(THIETHAN-3-YL)URACYL-3-YL]ACETIC ACID, DEMONSTRATING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2539301C1 |
| N-ACYLHYDRASONE DERIVATIVES FOR APPLICATION AS SELECTIVE INHIBITORS OF T-CELLS AND MEDICINES FOR LYMPHONEOPLASIA TREATMENT | 2013 |
|
RU2622651C2 |
| DERIVATIVES OF 2-THIOURACIL WITH ANTIADENOVIRAL ACTIVITY | 2017 |
|
RU2670204C1 |
